15250-m-cuypers

103 PCPCC study protocol 5 17. Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. BMJ. 2002;325(7370):961. 18. Vektis. Rapportage indicatoren indicatiestelling (praktijkvariatie). Zeist: Vektis; 2011. 19. Comprehensive Cancer Centre South. Factsheet Prostate cancer. Eindhoven: IKZ. 2012. 20. Healthcare Insurance Board. Robotprostaatchirurgie: Vanzelfsprekend? Diemen: CVZ; 2011. 21. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. Patient Decision Aids for Prostate Cancer Treatment: A Systematic Review of the Literature. CA: A Cancer Journal for Clinicians. 2009;59(6):379-90. doi:10.3322/caac.20039. 22. Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A et al. Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis. CA: A Cancer Journal for Clinicians. 2015; 65(3):239-51. 23. Feldman-Stewart D, Capirci C, Brennenstuhl S, Tong C, Abacioglu U, Gawkowska-Suwinska M et al. Information for Decision-making by Patients With Early-Stage Prostate Cancer A Comparison Across 9 Countries. Med Decis Making. 2011;31(5):754-66. 24. Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J et al. The Impact of Explicit Values Clarification Exercises in a Patient Decision Aid Emerges After the Decision Is Actually Made Evidence From a Randomized Controlled Trial. Med Decis Making. 2012;32(4):616-26. 25. ElwynG, O'Connor A, StaceyD,VolkR, EdwardsA, Coulter Aet al. International PatientDecision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aid: online international Delphi consensus process. BMJ. 2006;333(7565):417-9. 26. Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. Bmj. 2008;336(7649):876-80. 27. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj. 2008;337. 28. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328(7441):702-8. 29. Schellings R, Kessels A, Sturmans F. Prerandomisatie bij wetenschappelijk onderzoek: een taboe doorbroken. Ned Tijdschr Geneeskd. 2008;152(38):2053-6. 30. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol. 2000;57(3):315-21. 31. Van de Poll-Franse LV, Horevoorts N, Eenbergen Mv, Denollet J, Roukema JA, Aaronson NK et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188- 94. 32. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25-30. 33. Koedoot N, Molenaar S, Oosterveld P, Bakker P, de Graeff A, Nooy M et al. The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns. 2001;45(3):187-93.